List of companies in Nextech Invest's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited. | ||||||
Kronos Bio is a Cambridge, Massachusetts-based therapeutics company working on research and development of therapies that modulate historically recalcitrant cancer targets. | ||||||
Biotechnology company developing cell permeable macrocyclic peptide therapeutics using an automated chemistry synthesis. | ||||||
Blueprint Medicines is a biotechnology company that is working to improve human health. | ||||||
Small Molecules | ||||||
A pharmaceutical company developing protein degradation drugs to treat cancer and other diseases | ||||||
Arrakis is developing RNA-targeted small molecule (rSM) therapies to millions of patients. | ||||||
A2 Biotherapeutics, Inc. is a biotechnology research company developing T-cell therapies designed to attack solid tumors while sparing normal cells | ||||||
Turning Point Therapeutics, Inc. is a clinical-stage drug design company that specializes in the discovery and development of targeted cancer therapies | ||||||
EQRx Inc is a biotechnology company. Its pipeline programs include two pre-registrational oncology assets that have shown assuring Phase 3 data (aumolertinib and sugemalimab), and multiple other clinical-stage programs. | ||||||
IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality | ||||||
Boundless Bio is a pioneer in understanding and treating the most intractable cancers. They have charted a new spatial map of the cancer genome within cancer cells and are harnessing their scientific founders' discoveries about "extrachromosomal DNA," or ecDNA, to drive a revolution in cancer therapeutics. | ||||||
Silverback Therapeutics is a Seattle-based biopharmaceutical company developing ImmunoTAC therapies targeting previously inaccessible disease pathways. | ||||||
REVOLUTION Medicines is a small Molecules founded in 2014. | ||||||
ImaginAb is an immune and oncology imaging company developing a pipeline of novel products that give physicians unprecedented insights into the patient's health--enabling better patient selection and treatment monitoring for immuno-oncology therapies and other drugs. | ||||||
Vividion Therapeutics is a proprietary Screening founded in 2017. | ||||||
Black Diamond Therapeutics is a Biotechnology company. | ||||||
Neon Therapeutics is a biotechnology company developing immunotherapies for treating cancer. | ||||||
P53 regulators | ||||||
Cleave Therapeutics is a San Francisco-based biotechnology company focused on protein homeostasis and stress pathways in cancer and neurodegeneration. | ||||||
Small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins | ||||||
A company focused on the discovery and development of small molecule drugs for the treatment of diseases | ||||||
Moma Therapeutics is an enzymes - Molecular Machines. | ||||||
Exo Therapeutics is a small Molecule Drug Discovery. | ||||||
Alterome Therapeutics, Inc. is an oncology Treatments founded in 2021 by Eric Murphy. |
